IBT
LLY icon

International Biotechnology Trust’s Eli Lilly LLY Stock Holding History

International Biotechnology Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$2.77M – 56
2020
Q1 		$2.77M Buy
+20,000
New +$2.75M 1.26% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

International Biotechnology Trust's LLY Position: Q2 2020 in Review

International Biotechnology Trust sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 20,000 shares — an estimated $2.77M sold.

International Biotechnology Trust first reported a position in LLY in Q1 2020 and held it in 1 quarter. The position peaked at $2.77M in Q1 2020. 1,765 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • International Biotechnology Trust reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 20,000 Eli Lilly shares in Q2 2020, an estimated $2.77M.
  • International Biotechnology Trust first reported a position in Eli Lilly in Q1 2020 and held it in 1 quarter.
  • International Biotechnology Trust's Eli Lilly position peaked at $2.77M in Q1 2020.
  • 1,765 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on International Biotechnology Trust's 13F filing for Q2 2020, filed 14 Jul 2020.